This inventor holds 1 USPTO granted patent. Top assignees: Shiseido Company, Limited, The General Hospital Corporation. Active years: 1996.
Company Filing History:
1 out of 1,037 
1 out of 3,070 
Years Active: 1996
Title: The Innovations of Ethan L. Lerner
Introduction
Ethan L. Lerner is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of biotechnology, particularly through his innovative work on modified proteins. His research has implications for various medical applications, showcasing the potential of his inventions.
Latest Patents
Ethan L. Lerner holds a patent for a modified maxadilan protein, its preparation and use, and DNA encoding. This modified maxadilan protein exhibits higher biological activity than the native maxadilan derived from the sand fly Lutzomyia longipalpis. The invention includes a modified maxadilan fusion protein that contains a thrombin cleavage site, allowing for the production of the modified maxadilan as a fusion protein and its recovery after digestion with thrombin. The modified maxadilan is recognized as a potent vasodilator, highlighting its potential therapeutic applications.
Career Highlights
Throughout his career, Ethan has worked with prominent organizations, including Shiseido Company, Limited and The General Hospital Corporation. His experience in these institutions has contributed to his expertise in the field of biotechnology and protein engineering.
Collaborations
Ethan has collaborated with notable colleagues such as Manami Ohnuma and Masahiro Tajima. These partnerships have likely enriched his research and development efforts, fostering innovation in his projects.
Conclusion
Ethan L. Lerner's contributions to the field of biotechnology through his patented innovations demonstrate his commitment to advancing medical science. His work on modified maxadilan proteins exemplifies the potential for significant advancements in therapeutic applications.